Medasense Biometrics

Medasense Biometrics is seeking distributors that are active in OR, anesthesia and/or monitoring in Australia and New Zealand.

Medasense develops innovative systems and applications to objectively assess the physiological response to pain, providing insight throughout the pain.

Medasense’s leading product, PMD-200™, is an objective monitoring device based on the patented NOL™ technology that quantifies patients’ physiological response to pain.

Using the PMD-200™ in operating rooms and critical care units (where patients under general anesthesia are unable to communicate their pain), clinicians can optimize and personalize patients’ analgesic administration.

This may reduce the risk of  excessive use or underuse of analgesics that may result in significant complications.




%d bloggers like this: